Decreased risk of cancer in multiple sclerosis patients and analysis of the effect of disease modifying therapies on cancer risk-Reference-Cited by-同舟云学术

Decreased risk of cancer in multiple sclerosis patients and analysis of the effect of disease modifying therapies on cancer risk

Published:2016-11 Issue: Volume:370 Page:13-17
ISSN:0022-510X
Container-title:Journal of the Neurological Sciences
language:en
Short-container-title:Journal of the Neurological Sciences

Author:

Gaindh Deeya,Kavak Katelyn S.,Teter Barbara,Vaughn Caila B.,Cookfair Diane,Hahn Theresa,Weinstock-Guttman Bianca

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology

Reference29 articles.

1. National Institute of Neurological Disorders and Stroke. Multiple Sclerosis: Hope through Research;Office of Communications and Public Liaison,2014

2. Multiple sclerosis and risk of cancer: a meta-analysis;Handel;J. Neurol. Neurosurg. Psychiatry,2010

3. Multiple sclerosis and cancer in Norway. A retrospective cohort study;Midgard;Acta Neurol. Scand.,1996

4. Cancer incidence following hospitalization for multiple sclerosis in Denmark;Moller;Acta Neurol. Scand.,1991

5. Cutaneous malignancies in immunosuppressed organ transplant recipients;Seda;Skinmed,2014

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis Society;Multiple Sclerosis Journal;2024-02-15

2. Cancer risk, disease-modifying therapy, and age in multiple sclerosis: A retrospective population-based cohort study;Multiple Sclerosis and Related Disorders;2023-12

3. Comorbidity in the aging population with multiple sclerosis: a Danish nationwide study;Frontiers in Neurology;2023-11-24

4. Immunosenescence and multiple sclerosis: inflammaging for prognosis and therapeutic consideration;Frontiers in Aging;2023-10-13

5. Is cancer risk reduced in multiple sclerosis? Results from a tertiary referral center;Turkish Journal of Medical Sciences;2023-08-18